Enfortumab Vedotin (EV) in Combination with Pembrolizumab (P) Versus Chemotherapy in Previously Untreated Locally Advanced Metastatic Urothelial Carcinoma (la/muc): Subgroup Analyses Results from EV-302, a Phase 3 Global Study.
JOURNAL OF CLINICAL ONCOLOGY(2024)
关键词
Metastatic Bladder Cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要